1548 Federal Register / Vol. 71, No.

6 / Tuesday, January 10, 2006 / Notices

COMMUNITY LEVEL SURVEY BURDEN ESTIMATE—Continued

Number of re- Number of re- Hourly burden/ Total hourly
Survey section Content description spondents sponses response burden

172–178 ............................................ Contextual Factors and Closing 390 2 1.0 780

Questions.
Part II, 1–52 ...................................... Intervention Specific Information and 390 3 2.0 2,340
Adaptations.
53–60 ................................................ Intervention Outcomes ..................... 390 6 1.0 2,340
Sub-forms .......................................... Intervention Component Information 390 6 1.0 2,340
Review of past responses ................ ........................................................... 390 2 1.0 780

Total Community Level Year 3 ........................................................... ........................ 24 7.9 10,062

Burden.

Average Annual Community ........................................................... ........................ 21 8.1 8,827

Burden.

Send comments to Summer King, certification under the Mandatory standards to conduct drug and specimen
SAMHSA Reports Clearance Officer, Guidelines. validity tests on urine specimens:
Room 71–1044, One Choke Cherry If any laboratory has withdrawn from ACL Laboratories, 8901 W. Lincoln
Road, Rockville, MD 20857. Written the HHS National Laboratory Ave., West Allis, WI 53227. 414–328–
comments should be received within 60 Certification Program (NLCP) during the 7840/800–877–7016. (Formerly:
days of this notice. past month, it will be listed at the end, Bayshore Clinical Laboratory).
Dated: December 30, 2005.
and will be omitted from the monthly ACM Medical Laboratory, Inc., 160
listing thereafter. Elmgrove Park, Rochester, NY 14624.
Anna Marsh, This notice is also available on the
Director, Office of Program Services. 585–429–2264.
Internet at http://workplace.samhsa.gov Advanced Toxicology Network, 3560
[FR Doc. E6–95 Filed 1–9–06; 8:45 am] and http://www.drugfreeworkplace.gov. Air Center Cove, Suite 101, Memphis,
BILLING CODE 4162–20–P FOR FURTHER INFORMATION CONTACT: Mrs. TN 38118. 901–794–5770/888–290–
Giselle Hersh or Dr. Walter Vogl, 1150.
Division of Workplace Programs, Aegis Analytical Laboratories, Inc., 345
DEPARTMENT OF HEALTH AND SAMHSA/CSAP, Room 2–1035, 1 Choke Hill Ave., Nashville, TN 37210. 615–
HUMAN SERVICES Cherry Road, Rockville, Maryland 255–2400.
20857; 240–276–2600 (voice), 240–276– Baptist Medical Center-Toxicology
Substance Abuse and Mental Health
2610 (fax). Laboratory, 9601 I–630, Exit 7, Little
Services Administration
SUPPLEMENTARY INFORMATION: The Rock, AR 72205–7299. 501–202–2783.
Current List of Laboratories Which Mandatory Guidelines were developed (Formerly: Forensic Toxicology
Meet Minimum Standards To Engage in in accordance with Executive Order Laboratory Baptist Medical Center).
Urine Drug Testing for Federal 12564 and section 503 of Public Law Clinical Reference Lab, 8433 Quivira
Agencies 100–71. Subpart C of the Mandatory Road, Lenexa, KS 66215–2802. 800–
Guidelines, ‘‘Certification of 445–6917.
AGENCY: Substance Abuse and Mental Laboratories Engaged in Urine Drug Diagnostic Services, Inc., dba DSI,
Health Services Administration, HHS. Testing for Federal Agencies,’’ sets strict 12700 Westlinks Drive, Fort Myers,
standards that laboratories must meet in FL 33913. 239–561–8200/800–735–
ACTION: Notice. order to conduct drug and specimen 5416.
validity tests on urine specimens for Doctors Laboratory, Inc., 2906 Julia
SUMMARY: The Department of Health and
Federal agencies. To become certified, Drive, Valdosta, GA 31602. 229–671–
Human Services (HHS) notifies Federal an applicant laboratory must undergo 2281.
agencies of the laboratories currently three rounds of performance testing plus DrugScan, Inc., P.O. Box 2969, 1119
certified to meet the standards of an on-site inspection. To maintain that Mearns Road, Warminster, PA 18974.
Subpart C of the Mandatory Guidelines certification, a laboratory must 215–674–9310.
for Federal Workplace Drug Testing participate in a quarterly performance Dynacare Kasper Medical Laboratories,*
Programs (Mandatory Guidelines). The testing program plus undergo periodic, 10150–102 St., Suite 200, Edmonton,
Mandatory Guidelines were first on-site inspections. Alberta, Canada T5J 5E2. 780–451–
published in the Federal Register on Laboratories which claim to be in the 3702/800–661–9876.
April 11, 1988 (53 FR 11970), and applicant stage of certification are not to ElSohly Laboratories, Inc., 5 Industrial
subsequently revised in the Federal be considered as meeting the minimum Park Drive, Oxford, MS 38655. 662–
Register on June 9, 1994 (59 FR 29908), requirements described in the HHS 236–2609.
on September 30, 1997 (62 FR 51118), Mandatory Guidelines. A laboratory Express Analytical Labs, 3405 7th Ave.,
and on April 13, 2004 (69 FR 19644). must have its letter of certification from Suite 106, Marion, IA 52302. 319–
A notice listing all currently certified HHS/SAMHSA (formerly: HHS/NIDA) 377–0500.
laboratories is published in the Federal which attests that it has met minimum Gamma-Dynacare Medical
wwhite on PROD1PC65 with NOTICES

Register during the first week of each standards. Laboratories,* A Division of the
month. If any laboratory’s certification In accordance with Subpart C of the Gamma-Dynacare, Laboratory
is suspended or revoked, the laboratory Mandatory Guidelines dated April 13, Partnership, 245 Pall Mall Street,
will be omitted from subsequent lists 2004 (69 FR 19644), the following London, ONT, Canada N6A 1P4. 519–
until such time as it is restored to full laboratories meet the minimum 679–1630.

VerDate Aug<31>2005 16:09 Jan 09, 2006 Jkt 208001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\10JAN1.SGM 10JAN1
 Federal Register / Vol. 71, No. 6 / Tuesday, January 10, 2006 / Notices
General Medical Laboratories, 36 South
Brooks St., Madison, WI 53715. 608–
267–6225.
Kroll Scientific Testing Laboratories,
Inc., 450 Southlake Blvd., Richmond,
VA 23236. 804–378–9130. (Formerly:
Scientific Testing Laboratories, Inc.)
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040. 713–856–8288/
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869. 908–526–2400/800–437–4986.
(Formerly: Roche Biomedical
Laboratories, Inc.)
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709.
919–572–6900/800–833–3984.
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group.)
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121. 800–882–7272.
(Formerly: Poisonlab, Inc.)
Laboratory Corporation of America
Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122. 206–923–7020/
800–898–0180. (Formerly: DrugProof,
Division of Dynacare/Laboratory of
Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof,
Division of Laboratory of Pathology of
Seattle, Inc.)
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671. 866–827–8042/
800–233–6339. (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center.)
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449. 715–
389–3734/800–331–3734.
MAXXAM Analytics Inc.,* 6740
Campobello Road, Mississauga, ONT,
Canada L5N 2L8. 905–817–5700.
(Formerly: NOVAMANN (Ontario),
Inc.)
MedTox Laboratories, Inc., 402 W.
County Road D, St. Paul, MN 55112
651–636–7466/800–832–3244.
MetroLab-Legacy Laboratory Services,
1225 NE 2nd Ave., Portland, OR
97232. 503–413–5295/800–950–5295.
wwhite on PROD1PC65 with NOTICES
Minneapolis Veterans Affairs Medical
Center, Forensic Toxicology
Laboratory, 1 Veterans Drive,
Minneapolis, MN 55417. 612–725–
2088.
VerDate Aug<31>2005 16:09 Jan 09, 2006 Jkt 208001
National Toxicology Laboratories, Inc.,
1100 California Ave., Bakersfield, CA
93304. 661–322–4250/800–350–3515.
One Source Toxicology Laboratory, Inc.,
1213 Genoa-Red Bluff, Pasadena, TX
77504. 888–747–3774. (Formerly:
University of Texas Medical Branch,
Clinical Chemistry Division; UTMB
Pathology-Toxicology Laboratory.)
Oregon Medical Laboratories, P.O. Box
972, 722 East 11th Ave., Eugene, OR
97440–0972. 541–687–2134.
Pacific Toxicology Laboratories, 9348
DeSoto Ave., Chatsworth, CA 91311.
800–328–6942. (Formerly: Centinela
Hospital Airport Toxicology
Laboratory.)
Pathology Associates Medical
Laboratories, 110 West Cliff Dr.,
Spokane, WA 99204. 509–755–8991/
800–541–7897x7.
Physicians Reference Laboratory, 7800
West 110th St., Overland Park, KS
66210. 913–339–0372/800–821–3627.
Quest Diagnostics Incorporated, 3175
Presidential Dr., Atlanta, GA 30340.
770–452–1590/800–729–6432.
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline Bio-
Science Laboratories).
Quest Diagnostics Incorporated, 4770
Regent Blvd., Irving, TX 75063. 800–
824–6152. (Moved from the Dallas
location on 03/31/01; Formerly:
SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230
South Burnham Ave., Suite 250, Las
Vegas, NV 89119–5412. 702–733–
7866/800–433–2750. (Formerly:
Associated Pathologists Laboratories,
Inc.)
Quest Diagnostics Incorporated, 10101
Renner Blvd., Lenexa, KS 66219. 913–
888–3927/800–873–8845. (Formerly:
LabOne, Inc.; Center for Laboratory
Services, a Division of LabOne, Inc.)
Quest Diagnostics Incorporated, 400
Egypt Road, Norristown, PA 19403.
610–631–4600/877–642–2216.
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline Bio-
Science Laboratories).
Quest Diagnostics Incorporated, 506 E.
State Pkwy., Schaumburg, IL 60173.
800–669–6995/847–885–2010.
(Formerly: SmithKline Beecham
Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600
Tyrone Ave., Van Nuys, CA 91405.
818–989–2520/800–877–2520.
(Formerly: SmithKline Beecham
Clinical Laboratories).
Quest Diagnostics Incorporated, 2282
South Presidents Drive, Suite C, West
Valley City, UT 84120. 801–606–
6301/800–322–3361. (Formerly:
PO 00000 Frm 00044 Fmt 4703 Sfmt 4703
1549
Northwest Toxicology, a LabOne
Company; LabOne, Inc., dba
Northwest Toxicology; NWT Drug
Testing, NorthWest Toxicology, Inc.;
Northwest Drug Testing, a division of
NWT Inc.)
S.E.D. Medical Laboratories, 5601 Office
Blvd., Albuquerque, NM 87109, 505–
727–6300/800–999–5227.
South Bend Medical Foundation, Inc.,
530 N. Lafayette Blvd., South Bend,
IN 46601. 574–234–4176 x276.
Southwest Laboratories. 4645 E. Cotton
Center Boulevard, Suite 177, Phoenix,
AZ 85040. 602–438–8507/800–279–
0027.
Sparrow Health System, Toxicology
Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915.
517–364–7400. (Formerly: St.
Lawrence Hospital & Healthcare
System).
St. Anthony Hospital Toxicology
Laboratory, 1000 N. Lee St.,
Oklahoma City, OK 73101. 405–272–
7052.
Toxicology & Drug Monitoring
Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop
70 West, Suite 208, Columbia, MO
65203. 573–882–1273.
Toxicology Testing Service, Inc., 5426
N.W. 79th Ave., Miami, FL 33166.
305–593–2260.
US Army Forensic Toxicology Drug
Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755–
5235. 301–677–7085.
*The Standards Council of Canada
(SCC) voted to end its Laboratory
Accreditation Program for Substance
Abuse (LAPSA) effective May 12, 1998.
Laboratories certified through that
program were accredited to conduct
forensic urine drug testing as required
by U.S. Department of Transportation
(DOT) regulations. As of that date, the
certification of those accredited
Canadian laboratories will continue
under DOT authority. The responsibility
for conducting quarterly performance
testing plus periodic on-site inspections
of those LAPSA-accredited laboratories
was transferred to the U.S. HHS, with
the HHS’ NLCP contractor continuing to
have an active role in the performance
testing and laboratory inspection
processes. Other Canadian laboratories
wishing to be considered for the NLCP
may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to
be qualified, HHS will recommend that
DOT certify the laboratory (Federal
Register, July 16, 1996) as meeting the
minimum standards of the Mandatory
Guidelines published in the Federal
Register on April 13, 2004 (69 FR
E:\FR\FM\10JAN1.SGM 10JAN1
 1550 Federal Register / Vol. 71, No. 6 / Tuesday, January 10, 2006 / Notices
19644). After receiving DOT
certification, the laboratory will be
included in the monthly list of HHS-
certified laboratories and participate in
the NLCP certification maintenance
program.
Anna Marsh,
Director, Office Program Services, SAMHSA.
[FR Doc. E6–96 Filed 1–9–06; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
Endangered Species Recovery Permit
Application
AGENCY: Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of a permit
application.
SUMMARY: The following applicant has
applied for an enhancement of
propagation or survival permit to
conduct certain activities with
endangered species pursuant to section
10(a)(1)(A) of the Endangered Species
Act. The U.S. Fish and Wildlife Service
(‘‘we’’) solicits review and comment
from local, State and Federal agencies,
and the public on the following permit
request.
DATES: Comments on this permit
application must be received on or
before February 9, 2006.
ADDRESSES: Written data or comments
should be submitted to the U.S. Fish
and Wildlife Service, Chief, Endangered
Species, Ecological Services, 911 NE.
11th Avenue, Portland, Oregon 97232–
4181 (fax: 503–231–6243). Please refer
to the permit number when submitting
comments. All comments received,
including names and addresses, will
become part of the official
administrative record and may be made
available to the public.
FOR FURTHER INFORMATION CONTACT:
Documents and other information
submitted with this application are
available for review, subject to the
requirements of the Privacy Act and
Freedom of Information Act, by any
party who submits a written request for
a copy of such documents within 30
days of the date of publication of this
notice to the address above (telephone:
503–231–2063). Please refer to the
permit number when requesting copies
of documents.
wwhite on PROD1PC65 with NOTICES
SUPPLEMENTARY INFORMATION:
Permit No. TE–114934
Applicant: Idaho Department of Fish
and Game, Boise, Idaho.
VerDate Aug<31>2005 16:09 Jan 09, 2006 Jkt 208001
The applicant requests a permit to
take (harass by survey, capture, handle,
collar, take blood samples, relocate,
sacrifice, and release) the gray wolf
(Canis lupus) in conjunction with wolf
management activities in the State of
Idaho north of Interstate 90, for the
purpose of enhancing its survival.
The applicant proposes to: (a)
Conduct monitoring of wolf
populations; and (b) coordinate non-
lethal and lethal control actions to
reduce wolf conflicts with livestock and
dogs. These actions are currently
coordinated by the U.S. Fish and
Wildlife Service (Service). If the permit
is issued, the applicant would take on
responsibility for managing wolves in
northern Idaho. Wolf management
activities would be in accordance with
the requirements of the State of Idaho
Wolf Conservation and Management
Plan (March 2002) and the Service’s
Interim Wolf Control Plan for
Northwestern Montana and the
Panhandle of Northern Idaho (Control
Plan) (September 1999).
If issued, the permit would not affect
ongoing wolf management in the
remainder of the State of Idaho
conducted in accordance with the non-
essential experimental population
regulations found at 50 CFR 17.84(n).
We have determined that a practical,
responsive management program is
essential to enhancing survival of the
wolf in the wild (Service 1987; Service
1994; Service 1999). The program must
respond to wolf-livestock conflicts,
while promoting wolf recovery
objectives. The Control Plan provides
guidelines for: (a) Determining problem
wolf status (including investigative
procedures and criteria), (b) conducting
wolf control actions, and (c) disposition
of problem wolves.
We have made a preliminary
determination that issuance of this
permit would be categorically excluded
from further consideration under the
National Environmental Policy Act of
1969 (NEPA). If issued, the permit
would authorize Idaho Department of
Fish and Game to manage wolves in the
same manner that the Service has in the
6 years since the Control Plan was
adopted for northern Idaho. No
additional environmental impacts
would be expected beyond those
analyzed in the Service’s 1988
Environmental Assessment, the
Service’s 1999 Environmental Action
Memorandum, and the Control Plan.
The effect of the permit would be to
allow continuation of previously
analyzed and authorized activities;
therefore, its issuance would be an
administrative action.
PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\10JAN1.SGM
Our preliminary NEPA categorical
exclusion determination, the two wolf
plans noted above, and the Idaho
Department of Fish and Game permit
application, can be found at: http://
www.fws.gov/pacific/ecoservices/
endangered/recovery/default.htm.
Additional information about wolf
recovery and conservation in the
northwestern United States, including
control of problem wolves, can be found
in various reports at: http://
westerngraywolf.fws.gov/.
All comments received from
individuals become part of the official
public record. Requests for such
comments will be handled in
accordance with the Freedom of
Information Act and the Council on
Environmental Quality’s National
Environmental Protection Act
regulations [40 CFR 1506.6(f)]. Our
practice is to make comments, including
names and addresses of respondents,
available for public review during
regular business hours. Individual
respondents may request that we
withhold their home address from the
record, but this must be stated
prominently at the beginning of their
comments. We will honor these requests
to the extent allowable by law.
We solicit public review and
comment on this recovery permit
application.
Authority: This document is published
under the authority of the Endangered
Species Act of 1973, as amended (16 U.S.C.
1531 et seq.).
Dated: December 13, 2005.
David J. Wesley,
Acting Regional Director, Region 1, U.S. Fish
and Wildlife Service.
[FR Doc. E6–93 Filed 1–9–06; 8:45 am]
BILLING CODE 4310–55–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[NV–030–1610–DU]
Notice of Intent To Prepare an
Amendment to the Carson City Field
Office Consolidated Resource
Management Plan
AGENCY: Bureau of Land Management,
Interior.
ACTION: Notice of intent.
SUMMARY: This document provides
notice that the Bureau of Land
Management (BLM) intends to prepare a
Resource Management Plan (RMP)
amendment to address Lands and Land
Tenure Issues, and Recreation and
Travel Management. The appropriate
state, tribal and local governments will
10JAN1